As of Jul 22
| -0.16 / -2.14%|
The 6 analysts offering 12-month price forecasts for Cytosorbents Corp have a median target of 14.25, with a high estimate of 15.00 and a low estimate of 9.00. The median estimate represents a +94.41% increase from the last price of 7.33.
The current consensus among 5 polled investment analysts is to Buy stock in Cytosorbents Corp. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.